Dr. Gaber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6550 Fannin St
Ste 1661
Houston, TX 77030Phone+1 713-441-5141Fax+1 713-790-6839
Education & Training
Ain Shams University Faculty of MedicineClass of 1976
Certifications & Licensure
TX State Medical License 2006 - 2024
TN State Medical License 1987 - 2007
IL State Medical License 1985 - 1987
ME State Medical License Active through 1984- American Board of Surgery Surgery
Clinical Trials
- Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation Start of enrollment: 2010 Nov 01
- A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- 20 citationsImplantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats.Jesus Paez-Mayorga, Jocelyn Nikita Campa-Carranza, Simone Capuani, Nathanael Hernandez, Hsuan-Chen Liu
Nature Communications. 2022-12-26 - 12 citationsmTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to SARS-CoV-2 mRNA vaccines in solid organ transplant recipients.Sunjae Bae, Jennifer L Alejo, Teresa P Y Chiang, William A Werbel, Aaron A R Tobian
American Journal of Transplantation. 2022-12-01 - 2 citationsOutcomes of a High-Volume Organ Procurement Organization in the Era of Increasing Donation After Circulatory Death.Mark J Hobeika, Terri Menser, Kevin Myer, Adriana Lopez, Asad F Shaikh
Progress in Transplantation. 2022-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
